Antibody-mediated neutralization in vivo of infectious papillomaviruses
- PMID: 1693698
- PMCID: PMC249518
- DOI: 10.1128/JVI.64.7.3151-3156.1990
Antibody-mediated neutralization in vivo of infectious papillomaviruses
Abstract
Specific antibody-mediated neutralization of infectious human papillomavirus type 11 (HPV-11) was achieved in the athymic mouse xenograft system, in which HPV-11 induced morphological transformation of human foreskin. Virus-specific neutralization was demonstrated by the ability of an HPV-11-specific polyclonal antiserum to neutralize HPV-11 infectivity and not bovine papillomavirus type 1 (BPV-1) or cottontail rabbit papillomavirus (CRPV) infectivity. In all three virus infectivity systems, neutralization was detected by the failure of the virus suspension to induce morphological transformation of the appropriate skin xenografts placed under the renal capsule of athymic mice. Rabbit polyclonal antisera were also generated against intact virions of both BPV-1 and CRPV, and neutralizing activity was tested in the xenograft system with BPV-1 and fetal bovine skin and with CRPV and rabbit ear skin. The three polyclonal antisera contained virus-specific neutralizing antibodies, demonstrating that neutralizing epitopes existed on all three papillomaviruses and that these epitopes were antigenically non-cross-reactive. The athymic mouse xenograft system was a useful model for detecting papillomavirus-specific neutralizing antibodies and offers the only opportunity for the analysis of neutralizing antibodies to human papillomaviruses.
Similar articles
-
Induction of neutralizing antibodies to papillomaviruses by anti-idiotypic antibodies.Virology. 1995 Jul 10;210(2):292-301. doi: 10.1006/viro.1995.1346. Virology. 1995. PMID: 7542415
-
Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies.Virology. 1995 Feb 20;207(1):136-42. doi: 10.1006/viro.1995.1059. Virology. 1995. PMID: 7871722
-
Monoclonal antibody neutralization of BPV-1.Virus Res. 1993 May;28(2):195-202. doi: 10.1016/0168-1702(93)90136-b. Virus Res. 1993. PMID: 7686316
-
Recent advances in preclinical model systems for papillomaviruses.Virus Res. 2017 Mar 2;231:108-118. doi: 10.1016/j.virusres.2016.12.004. Epub 2016 Dec 9. Virus Res. 2017. PMID: 27956145 Free PMC article. Review.
-
Animal models of papillomavirus pathogenesis.Virus Res. 2002 Nov;89(2):249-61. doi: 10.1016/s0168-1702(02)00193-4. Virus Res. 2002. PMID: 12445664 Review.
Cited by
-
Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.J Virol. 1997 Aug;71(8):6247-52. doi: 10.1128/JVI.71.8.6247-6252.1997. J Virol. 1997. PMID: 9223527 Free PMC article.
-
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.J Virol. 1995 Jun;69(6):3959-63. doi: 10.1128/JVI.69.6.3959-3963.1995. J Virol. 1995. PMID: 7745754 Free PMC article.
-
Life cycle heterogeneity in animal models of human papillomavirus-associated disease.J Virol. 2002 Oct;76(20):10401-16. doi: 10.1128/jvi.76.20.10401-10416.2002. J Virol. 2002. PMID: 12239317 Free PMC article.
-
Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.J Virol. 1994 Nov;68(11):7570-4. doi: 10.1128/JVI.68.11.7570-7574.1994. J Virol. 1994. PMID: 7523700 Free PMC article.
-
How will HPV vaccines affect cervical cancer?Nat Rev Cancer. 2006 Oct;6(10):753-63. doi: 10.1038/nrc1973. Nat Rev Cancer. 2006. PMID: 16990853 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources